Top Markets
Coin of the day
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
Classement en actions #40012
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
Prix de l'action
$0.00733708
Dernière synchronisation: 2026-04-23
Capitalisation boursière
$273.87K
Changement (1 jour)
-39.13%
Changement (1 an)
-94.83%
Pays
NO
Échange PCI Biotech Holding ASA (PCIB)

Catégorie

Historique du prix de l'action pour PCI Biotech Holding ASA (PCIB)
Prix de clôture le plus élevé : $0.02 le 2026-04-01

Prix de clôture le plus bas : $1.50 le 2008-06-01
Historique du prix de l'action de PCI Biotech Holding ASA de 2008 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -3.83%
2025 -79.63%
2024 -36.96%
2023 -11.71%
2022 -84.13%
2021 -54.32%
2020 -59.39%
2019 143.06%
2018 1.83%
2017 93.21%
2016 351.92%
2015 -72.20%
2014 -40.12%
2013 -37.49%
2012 -10.04%
2011 -12.25%
2010 321.24%
2009 32.65%
2008 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.21%
KR
$259.89 14.81%
BE